GlobeNewswire

PaperCut brings easy, secure and sustainable printing to Germany

Dela

Global print management leader continues to amplify EMEA presence to address print management needs faced by German SMBs and manufacturers, among others

BRACKNELL, United Kingdom, April 19, 2018 (GLOBE NEWSWIRE) -- Leading print management software company PaperCut today announced its expansion into Germany.

The move reflects the company's investment in its European presence, ensuring customers throughout the EMEA region continue to receive the high-quality software, service and business agility PaperCut is known for. The German presence will address print management needs for PaperCut's growing customer base of small to medium-sized businesses (SMBs) and manufacturers, as well as other verticals including education, government and commercial organizations.

The German market has showcased excellent growth opportunities for PaperCut, and is the second of multiple countries in Europe - following the launch of its central EMEA office in the United Kingdom (UK) - where the company will continue expanding its presence. PaperCut's footprint in Germany continues its desire to provide consistent, high-quality support across local time zones, languages and geographies.

Since December 2016, the company has hired 20 industry and technology specialists throughout EMEA to ensure it maintains high customer service and innovation standards. Brought on board earlier this year, the Germany-based team includes a channel manager - formerly of HP - and a partner alliance manager - who joins PaperCut from Ricoh. Combined, they bring nearly 30 years of deep industry experience rooted in channel management and business development. The newest additions contribute to PaperCut's hand-picked team, which brings a unique background of experience in the industry.

"As Europe's largest and strongest economy, Germany is an important part of our growth throughout EMEA," said Chris Dance, co-founder and CEO of PaperCut. "Our global strategy is to make sure our customers and partners - regardless of where they're located - have convenient access to a local support network to help solve their print management needs. We're invested in the development of our EMEA presence, and our intentional focus on Germany will allow us to ensure we're continuing to uphold our standards that drive high-quality service, even as our business continues to grow in the region."

PaperCut's German employees are focused primarily on:

  • Establishing and growing the company's local presence to help drive acceleration within SMB and manufacturing, among other markets
  • Supporting the company's network of Authorized Solution Centers (ASCs), while developing and maintaining new and existing relationships

"It's our goal to exceed the expectations of our current and prospective customers on a global scale with the solutions and services we provide, and absolutely remains the case as we continue our expansion into Germany. Along with the expertise of our regional ASCs, we will provide local organizations the solutions they need to manage their printing and reduce their environmental impact," said Ad van Amrooij, global head of sales and channel at PaperCut. "The German marketplace has fostered an excellent environment for growth and opportunity, especially as it pertains to tackling environmental and security issues. We're keen to fill the critical gaps government, commercial and educational organizations experience to fulfill business objectives."

Currently, PaperCut has more than 19,000 customers in the EMEA region, a figure which continues to grow at an accelerated pace and represents over 40 percent of its revenue. The company's plans for continued expansion ensure comprehensive coverage of the vast Europe, Middle East and African regions.

To learn more about PaperCut's role in Germany, please visit https://www.papercut.com/ de/

About PaperCut Software
Around the world, workplaces are wrestling with printing costs and print management complexity. PaperCut is solving those problems, one workplace at a time. Since 1998, PaperCut has helped 50 million users in 175 countries save trillions of pages of paper. With PaperCut in their print environment, IT managers solve their nagging print problems once and for all. How? Its two software solutions - PaperCut MF and PaperCut NG - are cross-platform and vendor neutral. That means they work with any printer and any operating system. Plus, both solutions feature ground-breaking technology such as mobility print, secure print release, and rich reporting tools. Businesses of all shapes, sizes and industry benefit from the control, security and financial and environmental savings that PaperCut software was built for. Learn more at www.papercut.com.

Media Contact
Meghan Brown
10Fold Communications for PaperCut 
papercut@10fold.com 
415-800-5389




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Papercut Services North America LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

Karolinska Development's portfolio company Aprea presents promising results with APR-246 in combination with immuno-oncology agents3.4.2019 14:00:00 CESTPressmeddelande

STOCKHOLM, April 3, 2019. Karolinska Development's portfolio company Aprea today presents results from studies with APR-246 in combination with immune checkpoint blockade. The results show that APR-246 can improve the effect of immuno-oncology agents. Karolinska Development portfolio company Aprea Therapeutics announced today the results of studies with APR-246 in combination with immune checkpoint blockade. The results were presented by researchers from Memorial Sloan Kettering Cancer Center at the 2019 AACR Annual Meeting in Atlanta. The studies collectively support a role for p53 activity in the tumor microenvironment and suggest that stabilization of the tumor suppressor protein, p53, by APR-246 can enhance anti-tumor immune response, particularly when combined with immuno-oncology agents. The studies characterized changes in the tumor immune microenvironment in melanoma and colorectal cancer in vivo models when treated with APR-246 and immuno-oncology agents, either alone or in co

Karolinska Development's portfolio company Aprea presents promising results with APR-246 in combination with immuno-oncology agents3.4.2019 14:00:00 CESTPressmeddelande

STOCKHOLM, April 3, 2019. Karolinska Development's portfolio company Aprea today presents results from studies with APR-246 in combination with immune checkpoint blockade. The results show that APR-246 can improve the effect of immuno-oncology agents. Karolinska Development portfolio company Aprea Therapeutics announced today the results of studies with APR-246 in combination with immune checkpoint blockade. The results were presented by researchers from Memorial Sloan Kettering Cancer Center at the 2019 AACR Annual Meeting in Atlanta. The studies collectively support a role for p53 activity in the tumor microenvironment and suggest that stabilization of the tumor suppressor protein, p53, by APR-246 can enhance anti-tumor immune response, particularly when combined with immuno-oncology agents. The studies characterized changes in the tumor immune microenvironment in melanoma and colorectal cancer in vivo models when treated with APR-246 and immuno-oncology agents, either alone or in co

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum